These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 36689187)

  • 1. Interrogation of Functional miRNA-Target Interactions by CRISPR/Cas9 Genome Engineering.
    Wu Q; Michaels YS; Fulga TA
    Methods Mol Biol; 2023; 2630():243-264. PubMed ID: 36689187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrogation of Functional miRNA-Target Interactions by CRISPR/Cas9 Genome Engineering.
    Michaels YS; Wu Q; Fulga TA
    Methods Mol Biol; 2017; 1580():79-97. PubMed ID: 28439828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas9 screens reveal common essential miRNAs in human cancer cell lines.
    Merk DJ; Paul L; Tsiami F; Hohenthanner H; Kouchesfahani GM; Haeusser LA; Walter B; Brown A; Persky NS; Root DE; Tabatabai G
    Genome Med; 2024 Jun; 16(1):82. PubMed ID: 38886809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ functional dissection of RNA cis-regulatory elements by multiplex CRISPR-Cas9 genome engineering.
    Wu Q; Ferry QRV; Baeumler TA; Michaels YS; Vitsios DM; Habib O; Arnold R; Jiang X; Maio S; Steinkraus BR; Tapia M; Piazza P; Xu N; Holländer GA; Milne TA; Kim JS; Enright AJ; Bassett AR; Fulga TA
    Nat Commun; 2017 Dec; 8(1):2109. PubMed ID: 29235467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding functional miRNA-target interactions in vivo by site-specific genome engineering.
    Bassett AR; Azzam G; Wheatley L; Tibbit C; Rajakumar T; McGowan S; Stanger N; Ewels PA; Taylor S; Ponting CP; Liu JL; Sauka-Spengler T; Fulga TA
    Nat Commun; 2014 Aug; 5():4640. PubMed ID: 25135198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-focused CRISPR-Cas9 library screen reveals fitness-associated miRNAs.
    Kurata JS; Lin RJ
    RNA; 2018 Jul; 24(7):966-981. PubMed ID: 29720387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Efficient CRISPR-Cas9 Method to Knock Out MiRNA Expression in Xenopus Tropicalis.
    Godden AM; Antonaci M; Wheeler GN
    Methods Mol Biol; 2023; 2630():231-241. PubMed ID: 36689186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derepression of specific miRNA-target genes in rice using CRISPR/Cas9.
    Lin Y; Zhu Y; Cui Y; Chen R; Chen Z; Li G; Fan M; Chen J; Li Y; Guo X; Zheng X; Chen L; Wang F
    J Exp Bot; 2021 Oct; 72(20):7067-7077. PubMed ID: 34283216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A microRNA-inducible CRISPR-Cas9 platform serves as a microRNA sensor and cell-type-specific genome regulation tool.
    Wang XW; Hu LF; Hao J; Liao LQ; Chiu YT; Shi M; Wang Y
    Nat Cell Biol; 2019 Apr; 21(4):522-530. PubMed ID: 30804503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of miRNA sequences by TALENs and CRISPR/Cas9 induces varied lengths of miRNA production.
    Bi H; Fei Q; Li R; Liu B; Xia R; Char SN; Meyers BC; Yang B
    Plant Biotechnol J; 2020 Jul; 18(7):1526-1536. PubMed ID: 31821678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Role of CRISPR/Cas9 Technology for MicroRNAs Editing in Cancer Research.
    Aquino-Jarquin G
    Cancer Res; 2017 Dec; 77(24):6812-6817. PubMed ID: 29208606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9 Tool for MicroRNAs Editing in Cardiac Development, Function, and Disease.
    Abkhooie L; Saberianpour S
    Microrna; 2023; 12(1):13-21. PubMed ID: 36154577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identify Myeloid Differentiation-Related MiRNAs Response to ATRA Induction by RNA Sequencing and CRISPR/Cas9 Gene Editing].
    Wang LY; Lin RZ; Jiang PF; Zhang Y; Li JZ; Chen YW; Hu JD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):339-347. PubMed ID: 33812397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas9 Based Genome Editing Reveals New Insights into MicroRNA Function and Regulation in Rice.
    Zhou J; Deng K; Cheng Y; Zhong Z; Tian L; Tang X; Tang A; Zheng X; Zhang T; Qi Y; Zhang Y
    Front Plant Sci; 2017; 8():1598. PubMed ID: 28955376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9-mediated fine-tuning of miRNA expression in tetraploid potato.
    Lukan T; Veillet F; Križnik M; Coll A; Mahkovec Povalej T; Pogačar K; Stare K; Chauvin L; Chauvin JE; Gruden K
    Hortic Res; 2022; 9():uhac147. PubMed ID: 36072839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient deletion of microRNAs using CRISPR/Cas9 with dual guide RNAs.
    Ijee S; Chambayil K; Chaudhury AD; Bagchi A; Modak K; Das S; Benjamin ESB; Rani S; Paul DZ; Nath A; Roy D; Palani D; Priyanka S; Ravichandran R; Kumary BK; Sivamani Y; S V; Babu D; Nakamura Y; Thamodaran V; Balasubramanian P; Velayudhan SR
    Front Mol Biosci; 2023; 10():1295507. PubMed ID: 38628442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo mutagenesis of miRNA gene families using a scalable multiplexed CRISPR/Cas9 nuclease system.
    Narayanan A; Hill-Teran G; Moro A; Ristori E; Kasper DM; A Roden C; Lu J; Nicoli S
    Sci Rep; 2016 Aug; 6():32386. PubMed ID: 27572667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9 System to Knockdown MicroRNA In Vitro and In Vivo.
    Yi B; Larter K; Xi Y
    Methods Mol Biol; 2021; 2300():133-139. PubMed ID: 33792878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficiency of Recombinant CRISPR/rCas9-Mediated miRNA Gene Editing in Rice.
    Chung PJ; Chung H; Oh N; Choi J; Bang SW; Jung SE; Jung H; Shim JS; Kim JK
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.